These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Evaluation of mexiletine effect on conduction delay and bradyarrhythmic complications in patients with myotonic dystrophy type 1 over long-term follow-up. Vio R; Zorzi A; Bello L; Bozzoni V; Botta A; Rivezzi F; Leoni L; Migliore F; Bertaglia E; Iliceto S; Pegoraro E; Corrado D; Calore C Heart Rhythm; 2020 Nov; 17(11):1944-1950. PubMed ID: 32525073 [TBL] [Abstract][Full Text] [Related]
3. Cardiac involvement in myotonic muscular dystrophy. Moorman JR; Coleman RE; Packer DL; Kisslo JA; Bell J; Hettleman BD; Stajich J; Roses AD Medicine (Baltimore); 1985 Nov; 64(6):371-87. PubMed ID: 4058303 [TBL] [Abstract][Full Text] [Related]
4. [Myotonic dystrophy and heart disease: behavior of arrhythmic events and conduction disturbances]. Nishioka SA; Martinelli Filho M; Marie S; Zatz M; Costa R Arq Bras Cardiol; 2005 Apr; 84(4):330-6. PubMed ID: 15880208 [TBL] [Abstract][Full Text] [Related]
5. Electrocardiographic abnormalities and sudden death in myotonic dystrophy type 1. Groh WJ; Groh MR; Saha C; Kincaid JC; Simmons Z; Ciafaloni E; Pourmand R; Otten RF; Bhakta D; Nair GV; Marashdeh MM; Zipes DP; Pascuzzi RM N Engl J Med; 2008 Jun; 358(25):2688-97. PubMed ID: 18565861 [TBL] [Abstract][Full Text] [Related]
6. Cardiac conduction in myotonic dystrophy. Griggs RC; Davis RJ; Anderson DC; Dove JT Am J Med; 1975 Jul; 59(1):37-42. PubMed ID: 1138549 [TBL] [Abstract][Full Text] [Related]